STOCK TITAN

Insiders report holdings at Shoulder Innovations (NASDAQ: SI) in 13G/A

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Shoulder Innovations, Inc. amendment to a Schedule 13G/A reports beneficial ownership positions held by cultivate(MD) Holdings, LLC and four associated reporting persons. The filing states 15,936 shares held by Cultivate MD Capital Fund I, LLC and cites 20,647,526 shares outstanding as of March 3, 2026 used to calculate percentages. Individual reported beneficial amounts include 300,939 for David L. Blue (1.5%), 317,137 for Matthew F. Ahearn (1.5%), 767,809 for Robert J. Ball (3.6%), and 155,052 for R. Sean Churchill (0.8%).

Positive

  • None.

Negative

  • None.
Shares outstanding used 20,647,526 shares as of March 3, 2026 (Form 10-K basis)
CMD I holdings 15,936 shares held of record by Cultivate MD Capital Fund I, LLC
David L. Blue beneficial ownership 300,939 shares reported total; <percent>1.5%</percent> of class
Matthew F. Ahearn beneficial ownership 317,137 shares reported total; <percent>1.5%</percent> of class
Robert J. Ball beneficial ownership 767,809 shares reported total; <percent>3.6%</percent> of class
R. Sean Churchill beneficial ownership 155,052 shares reported total; <percent>0.8%</percent> of class
beneficially owned regulatory
"aggregate number of shares of common stock beneficially owned by the Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting and dispositive power regulatory
"cultivate(MD) Holdings, LLC has sole voting and dispositive power with respect to the shares held by CMD I"
Rule 13d-3 regulatory
"The percentage in row 11 is calculated in accordance with Rule 13d-3"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Joint Filing Agreement other
"Joint Filing Agreement, dated November 12, 2025, by and among the Reporting Persons"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





82537J108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage in row 11 is calculated in accordance with Rule 13d-3 based on the aggregate number of shares of common stock beneficially owned by the Reporting Person and an aggregate of 20,647,526 shares of common stock outstanding as of March 3, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Sole Voting and Dispositive Powers include: (i) 95,435 shares of common stock held by Mr. Blue; (ii) 118,274 shares of common stock held by the David Blue Living Trust; (iii) options to purchase 18,791 shares of common stock held by Mr. Blue that vest within 60 days of April 27, 2026; and (iv) options to purchase 52,503 shares of common stock held by the David Blue Living Trust that vest within 60 days of April 27, 2026. (2) The percentage in row 11 is calculated in accordance with Rule 13d-3 based on the aggregate number of shares of common stock beneficially owned by the Reporting Person and an aggregate of 20,647,526 shares of common stock outstanding as of March 3, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025, plus the number of options held by the Reporting Person that vest within 60 days of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Sole Voting and Dispositive Powers include options to purchase 12,025 shares of common stock that vest within 60 days of April 27, 2026. (2) The percentage in row 11 is calculated in accordance with Rule 13d-3 based on the aggregate number of shares of common stock beneficially owned by the Reporting Person and an aggregate of 20,647,526 shares of common stock outstanding as of March 3, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025, plus the number of options held by the Reporting Person that vest within 60 days of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Sole Voting and Dispositive Powers include: (i) 252,986 shares of common stock held by Mr. Ball; (ii) 37,032 shares of common stock held jointly by Mr. Ball and his spouse; and (iii) options to purchase 461,855 shares of common stock that vest within 60 days of April 27, 2026. (2) The percentage in row 11 is calculated in accordance with Rule 13d-3 based on the aggregate number of shares of common stock beneficially owned by the Reporting Person and an aggregate of 20,647,526 shares of common stock outstanding as of March 3, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025, plus the number of options held by the Reporting Person that vest within 60 days of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage in row 11 is calculated in accordance with Rule 13d-3 based on the aggregate number of shares of common stock beneficially owned by the Reporting Person and an aggregate of 20,647,526 shares of common stock outstanding as of March 3, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G



cultivate(MD) Holdings, LLC
Signature:/s/ R. Sean Churchill
Name/Title:Managing Director
Date:05/07/2026
Blue David Lawrence
Signature:/s/ David Lawrence Blue
Name/Title:David Lawrence Blue
Date:05/07/2026
Ahearn Matthew Fraser
Signature:/s/ Matthew Fraser Ahearn
Name/Title:Matthew Fraser Ahearn
Date:05/07/2026
Ball Robert Joseph
Signature:/s/ Robert Joseph Ball
Name/Title:Robert Joseph Ball
Date:05/07/2026
Churchill R. Sean
Signature:/s/ R. Sean Churchill
Name/Title:R. Sean Churchill
Date:05/07/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement, dated November 12, 2025, by and among the Reporting Persons (incorporated by reference to Exhibit 99.1 of Schedule 13G filed with the SEC on November 12, 2025).